Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double-antibody combined fluorescence detection kit for liver cancer resection postoperative prognosis

A fluorescent detection and double-antibody technology, applied in measuring devices, instruments, disease diagnosis, etc., can solve problems such as difficulty in distinguishing the expression of tumor cells and immune cells, limited curative effect judgment, etc., and achieve mature test methods, easy repeatability, and detection process easy effect

Inactive Publication Date: 2018-08-14
SUN YAT SEN UNIV CANCER CENT
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, traditional immunohistochemical staining is used to evaluate the expression of PD-L1 clinically, and it is difficult to distinguish the expression of tumor cells and immune cells, so the ability to judge the efficacy is limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-antibody combined fluorescence detection kit for liver cancer resection postoperative prognosis
  • Double-antibody combined fluorescence detection kit for liver cancer resection postoperative prognosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] The double-antibody combined fluorescence detection kit for prognosis after liver cancer resection according to the present invention includes a first antibody and a second antibody, and the first antibody includes an antibody for detecting the following two protein molecular markers: CD68 (Cell Differentiation Antigen 68), PD-L1 (Programmed Death Ligand 1); also includes TSA (Tyramide Signal Amplifying Reagent). The secondary antibody is a horseradish peroxidase-labeled secondary antibody.

[0017] For the double-antibody combined fluorescence detection kit described in the present invention, its effectiveness is tested through the following steps.

[0018] (1) Specimen testing

[0019] 1. Select the paraffin section of liver cancer that includes the tumor area, and ensure that there is no large necrosis;

[0020] 2. Obtain 8 paraffin sections of 4 μm, bake the slices at 60°C for 2 hours, take them out, and cool slightly;

[0021] 3. Dewax with xylene twice at room ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a double-antibody combined fluorescence detection kit for liver cancer resection postoperative prognosis. The double-antibody combined fluorescence detection kit for liver cancer resection postoperative prognosis comprises a first antibody and a second antibody, wherein the first antibody is selected from the antibody combination of the following protein molecular markers:CD68 (cell differentiation antigen 68) and PD-L1 (procedural death ligand 1). The kit uses double-antibody combination indexes; the expression mode of the PD-L1 in tissues can be precisely reflected,so that the prognosis of a patient is better evaluated; the kit can help doctors to select the proper treatment user groups and modes, so that the powerful support is provided for effective diagnosisand treatment.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a double-antibody combined fluorescence detection kit for prognosis after liver cancer resection, in particular to a double-antibody combined fluorescence detection kit for detecting PD-L1 molecular expression patterns in liver cancer tissues . Background technique [0002] Primary hepatocellular carcinoma (hereafter referred to as liver cancer) is one of the most common malignant tumors with the worst prognosis in my country, and its morbidity and mortality rank among the forefront of malignant tumors. At present, the most effective methods for the treatment of liver cancer are still surgical resection and liver transplantation; however, most patients are already in the middle and advanced stages when they are diagnosed, and do not have the indications and conditions for surgery. Survival rates are still low. A large number of clinical trials in recent years have proved that immunot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574G01N33/533
CPCG01N33/533G01N33/57438G01N2800/085
Inventor 郑利民陈敏山许静刘超群张耀军石明
Owner SUN YAT SEN UNIV CANCER CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com